Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)
China
· Delayed Price · Currency is CNY
33.90
+0.25 (0.74%)
Nov 20, 2024, 3:00 PM CST
Tianjin Pharmaceutical Da Ren Tang Group Corporation Revenue
Tianjin Pharmaceutical Da Ren Tang Group Corporation had revenue of 1.65B CNY in the quarter ending September 30, 2024, a decrease of -3.43%. This brings the company's revenue in the last twelve months to 8.04B, down -5.18% year-over-year. In the year 2023, Tianjin Pharmaceutical Da Ren Tang Group Corporation had annual revenue of 8.22B, down -0.33%.
Revenue (ttm)
8.04B
Revenue Growth
-5.18%
P/S Ratio
3.22
Revenue / Employee
1.74M
Employees
4,619
Market Cap
22.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.22B | -26.94M | -0.33% |
Dec 31, 2022 | 8.25B | 1.34B | 19.42% |
Dec 31, 2021 | 6.91B | 303.89M | 4.60% |
Dec 31, 2020 | 6.60B | -390.23M | -5.58% |
Dec 31, 2019 | 6.99B | 635.26M | 9.99% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition